Skip to main content
Figure 5 | Child and Adolescent Psychiatry and Mental Health

Figure 5

From: Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence

Figure 5

Projected impact of ADHD treatment for children and adolescents on individual physicians' prescription drug expenditures, 2001–2012 (base case). a: Child and adolescent psychiatrists; b: pediatricians in private practice in Germany. Expenditures expressed as €/physician and year; perspective of statutory health insurance (i.e., excluding privately health insured patients). Data represent average values for one of the upper 50% of child and adolescent psychiatrists and one of the upper 20% of pediatricians in terms of relative involvement in care for ADHD patients, respectively. Concentration of care modeled according to Nordbaden data [74]. Abbreviation: Non-ADHD-Rx: expenditures for treatment of conditions other than ADHD.

Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000